Product Information
LACOSAMIDE 150 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.2075 per EA under NDC 51991035006. Its NADAC has been published 210 times since Jun 22, 2022.
Strength
150 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991035006
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204921On Market Since
3/18/2022
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 150 MG TABLET has been published 210 times since Jun 22, 2022, and over the history we have for it it has declined 51.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2075 per EA |
|---|---|
| All-time high | $0.4317 (Jul 13, 2022) |
| All-time low | $0.2069 (May 20, 2026) |
| 52-week high | $0.2664 |
| 52-week low | $0.2069 |
| Median price | $0.3084 |
| Average price | $0.3194 |
| Largest weekly change | +42.0% (Aug 21, 2024) |
| Weeks tracked | 210 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LACOSAMIDE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 150 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $0.2075 per EA (NDC 51991035006), effective Jun 24, 2026.
How has the price of LACOSAMIDE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 150 MG TABLET has declined 51.9%. It has been tracked across 210 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 150 MG TABLET?
Since Jun 22, 2022, the NADAC for LACOSAMIDE 150 MG TABLET has ranged from a low of $0.2069 (May 20, 2026) to a high of $0.4317 (Jul 13, 2022), with a median of $0.3084 per EA.
Are there cheaper alternatives to LACOSAMIDE 150 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LACOSAMIDE 150 MG TABLET, but none are currently priced below it.
Who manufactures LACOSAMIDE 150 MG TABLET?
LACOSAMIDE 150 MG TABLET (NDC 51991035006) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification